Diligence memo · auto-generated · as of July 2, 2026

Gestalt Diagnostics, LLC

Gestalt Diagnostics, LLC looks over-valued against its niche peers and is active on financing cadence.

SourceRaising on rhythm with a 22.3× step-up on the last round — momentum worth tracking before it's priced in.

Businessfiled

Gestalt Diagnostics, LLC operates in Medical Devices, based in SPOKANE.

Sub-sector tags: medical-devices.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Gestalt Diagnostics, LLC has raised $9.6M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).

Largest single filing: $6.7M on 2025-03-14.

Most recent recorded round closed around 2025-03-14.

Valuation (modeled)modeled

Provath models Gestalt Diagnostics, LLC at approximately $25M (range $8.2M–$46M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 2.44× the median modeled value of Series A Medical Devices companies in 2025–2027 (10 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 48 months.

Last raise 16 mo ago; this sector typically re-raises about every 16 months.

Raising on or ahead of the sector's normal rhythm.

The last round stepped up 22.3× from the prior — scaling.

Comparablesmixed

Capital scale ranks ahead of 76% of Medical Devices peers (233 compared).

Modeled value ranks above 65% of those peers.

Closest niche peers: Curadel Surgical Innovations, Inc., ClearCut Surgical, Inc., Bayou Surgical, Inc., AI Diagnostics, NexEos Diagnostics, Inc..

Peoplefiled

12 named people on file across officers, directors and signatories.

Risks & flagsmixed

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.